Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients

Hannah K. Batchelor*, Richard Kendall, Sabine Desset-Brethes, Rainer Alex, Terry B. Ernest

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

46 Citations (Scopus)

Abstract

Biopharmaceutics is routinely used in the design and development of medicines to generate science based evidence to predict in vivo performance; the application of this knowledge specifically to paediatric medicines development is yet to be explored. The aim of this review is to present the current status of available biopharmaceutical tools and tests including solubility, permeability and dissolution that may be appropriate for use in the development of immediate release oral paediatric medicines. The existing tools used in adults are discussed together with any limitations for their use within paediatric populations. The results of this review highlight several knowledge gaps in current methodologies in paediatric biopharmaceutics. The authors provide recommendations based on existing knowledge to adapt tests to better represent paediatric patient populations and also provide suggestions for future research that may lead to better tools to evaluate paediatric medicines.

Original languageEnglish
Pages (from-to)833-842
Number of pages10
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume85
Issue number3 PART B
DOIs
Publication statusPublished - 1 Nov 2013

Keywords

  • absorption
  • bioavailability
  • biopharmaceutics
  • dissolution
  • paediatric
  • permeability
  • solubility

Fingerprint

Dive into the research topics of 'Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients'. Together they form a unique fingerprint.

Cite this